Lescarden Inc (LCAR) Financial Statements (2024 and earlier)

Company Profile

Business Address 420 LEXINGTON AVE.
NEW YORK, NY 10170
State of Incorp. NY
Fiscal Year End May 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

2/28/2017
MRQ
5/31/2016
5/31/2015
5/31/2014
5/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 4371085
Cash and cash equivalents 4371085
Receivables 149227
Inventory, net of allowances, customer advances and progress billings 19884114148
Inventory 19884114148
Total current assets: 204170126260
Noncurrent Assets
TOTAL ASSETS: 204170126260
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 309173221267
Other undisclosed accounts payable and accrued liabilities 309173221267
Debt 279269 347
Deferred compensation liability   511
Total current liabilities: 588442225625
Noncurrent Liabilities
Other undisclosed liabilities    5
Total liabilities: 588442225630
Equity
Equity, attributable to parent, including: (385)(272)(99)(370)
Common stock 64646449
Additional paid in capital 17,50617,50617,50617,074
Accumulated deficit (17,956)(17,843)(17,670)(17,494)
Other undisclosed equity, attributable to parent 2222
Total equity: (385)(272)(99)(370)
TOTAL LIABILITIES AND EQUITY: 204170126260

Income Statement (P&L) ($ in thousands)

2/28/2017
TTM
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Revenues
(Revenue, Net)
 120253397403
Cost of revenue (33)(110)(197)(520)
Cost of goods and services sold (13)(63)(174)(173)
Gross profit: 86143200(117)
Operating expenses (199)(339)(376)(185)
Operating loss: (113)(196)(176)(302)
Interest and debt expense (0)(1)(2)(5)
Loss from continuing operations: (113)(197)(179)(307)
Loss before gain (loss) on sale of properties: (113)(197)(179)(307)
Net loss: (113)(197)(179)(307)
Other undisclosed net income attributable to parent 03249
Net loss available to common stockholders, diluted: (113)(193)(176)(257)

Comprehensive Income ($ in thousands)

2/28/2017
TTM
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Net loss: (113)(197)(179)(307)
Comprehensive loss, net of tax, attributable to parent: (113)(197)(179)(307)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: